Team Grant : Pediatric concussion CIHR-NIH 2019
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Tuesday 9th, April 2019
External Deadline: Friday 12th, April 2019
Description
Concussion is recognized as a serious public health epidemic, particularly in children, where rates have doubled over the last decade, with an estimated 750,000 pediatric acute concussion visits to emergency departments (EDs) occurring annually in the United States alone. While many children experience symptom resolution within 2 weeks, approximately 33% experience ongoing cognitive, somatic, psychological, behavioural symptoms, or a combination of these symptoms, known as “Persistent Post-Concussive Symptoms, or PPCS”.
In 2012 Canada (through CIHR) became one of three founding countries in the “International Initiative for TBI Research (InTBIR), along with the European Union (EU Health Directorate) and the United States (NIH-NINDS). As part of the executive leadership in InTBIR, The Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) and partners launched $10M worth of funding opportunities including five team grants in pediatric concussion. In March 2016 one of these teams, led by Roger Zemek, published the first clinical prediction tool to identify children at risk of PPCS) Given the leadership role of Canadian researchers in concussion, CIHR-INMHA was approached by its InTBIR partner NIH-NINDS to participate on this new bilateral funding opportunity.
This funding opportunity represents the next step of the continuing Canadian and American investments into pediatric concussion research, care, and knowledge exchange.
For more information, please consult the NIH call. (Updated: 2019-03-22)
Research Areas
This funding opportunity will support the Canadian team component of a multi-site, multidisciplinary, research team that works synergistically to discover, characterize, and validate a combination of biological measures for prognosis and/or monitoring recovery of persistent concussive symptoms with enrollment from multiple points of care and participants with a variety of injury mechanisms. Biological measures that are responsive may include, but are not limited to neuroimaging, functional measures, sensory processing, metabolomics, proteomics, and other biofluid-based assays.
For more information, please consult the NIH call. (Updated: 2019-03-22)
Please see detailed description on Research Net